Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Firsekibart Versus Anakinra in Adult-Onset Still's Disease

NCT07191444 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07191444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 24, 2025
Completion date
July 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

still's disease, adult-onset